Bioequivalence of IMP 08P1707F0 Relative to Pulmicort (1.0 Mg/2 Ml Suspension)
Status:
COMPLETED
Trial end date:
2024-09-16
Target enrollment:
Participant gender:
Summary
This study aims to demonstrate the bioequivalence between the formulation of Budesonide 1mg/2mL nebuliser suspension (IMP 08P1707F0) relaive to the reference product Pulmicort(r) 1.0mg/2mL suspension.